AI Tool Measures Fat Around the Heart to Predict Diabetes Risk designnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from designnews.com Daily Mail and Mail on Sunday newspapers.
HIV research center set up in the UK to address health inequalities and develop new treatments
Jul 12 2021
A trailblazing HIV research center is being set up in the UK to address health inequalities and improve quality of life for everyone affected by HIV.
The dedicated center, based in London, will explore why some groups of people fare much worse than others following an HIV diagnosis.
The team of clinicians, scientists, and members of the community will find ways to prevent future HIV infections and trial innovative new treatments.
In the past, HIV infection nearly always resulted in death, but now, with prompt diagnosis and the right treatment, it can be a manageable long-term condition with those affected likely to live long and healthy lives.
Fact check: Did COVID vaccines cause the delta variant? | Health | DW dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.
Risk of recurring kidney cancer can be reduced by using old drug at earlier stage ANI | Updated: Jul 11, 2021 08:51 IST
Washington [US], July 11 (ANI): According to the findings of new research, using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third.
The findings from the Phase III trial were presented at the European Association of Urology Congress (EAU21). There is a high risk of kidney cancer returning, following surgery to remove tumours, but there is currently no treatment to help prevent this.
The KEYNOTE study involved just under 1000 patients with kidney cancer who had undergone surgery. Half of them were given the immunotherapy drug pembrolizumab, or pembro, and the other half a placebo.
Stimulating immune cells to form special structures can potentiate pancreatic cancer chemotherapy
A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy.
The body s immune system is a critical defense against illness such as infections, as has been highlighted by the recent COVID-19 pandemic. The same immune system can also help us fight cancer. However, pancreatic cancer is different; a key feature of this cancer type is that the pancreatic cancer cells are surrounded by a dense, impenetrable barrier known as the stroma, which often blocks the access of immune cells to the tumor. For this reason, immunotherapies - drugs that harness the power of the body s immune system to kill cancer cells - have shown limited success in the treatment of pancreatic cancer,